Fimasartan 120mg

DRUG2 trials

Sponsors

Boryung Pharmaceutical Co., Ltd

Conditions

Essential Hypertension, DyslipidemiaHypertension

Phase 3

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

CompletedNCT01135212

Boryung Pharmaceutical Co., LtdHypertension

Start: 2010-04-30End: 2011-05-31Updated: 2012-08-24

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia

CompletedNCT03338426

Boryung Pharmaceutical Co., LtdEssential Hypertension, Dyslipidemia

Start: 2018-01-15End: 2019-04-22Updated: 2019-11-05

Related Papers

A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension.

2016-05-069 citations

2011-08-019 citations